Cotinga Pharmaceuticals Inc. Stock Toronto S.E.
Equities
COT
CA22675B2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -41.67% |
|
-22.22% | -41.67% |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.21M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.48M | Net income 2019 | -2M -2.74M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.78K | Net cash position 2019 | 24.64K 33.75K | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
1 day | -41.67% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+18.12% | 126B | |
+22.82% | 118B | |
+23.26% | 27.87B | |
-18.47% | 20.95B | |
-15.13% | 16.92B | |
-15.37% | 16.18B | |
+9.54% | 14.84B | |
-46.10% | 14.79B | |
+52.50% | 14.08B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock